Breakfast Briefing, 3.24.2017: Twitter teases Tweetdeck on steroids

Twitter is surveying users about what they'd like to see in a paid-for version of TweetDeck.

Twitter teases Tweetdeck on steroids
The social network is asking users what enhancements they want in a souped-up, paid version of Tweetdeck for super-users such as brands and media companies, according to several reports. The bulked-up edition of Twitter could include analytics, breaking news alerts, and information on what users are tweeting about, according to The Verge.


Google still hasn’t fixed YouTube ad issues
Top-tier marketers in Europe and Asia are still seeing their ads appear on YouTube next to extremist content, according to Bloomberg. Earlier this week, AT&T and Johnson & Johnson said they will stop running ads on the platform, despite Google’s pledge to crack down on ads appearing next to extremist content, such as anti-semitic or pro-terrorist videos.

Samsung apologizes for scandals
Kwon Oh-hyun, vice chairman of Samsung Electronics, apologized to shareholders early Friday for the company’s involvement in a corruption scandal involving South Korea’s president, according to Bloomberg. The company’s top executive and heir apparent, Jay Lee, is still being held by authorities, for his alleged role in the scandal.

All eyes on the healthcare vote
Dominating Friday morning’s news cycle: the House of Representatives is set to vote on the American Health Care Act, known in some circles as "Trumpcare," after the president issued an ultimatum to legislators in his own party late Thursday. The White House told lawmakers it is finished negotiating the bill, and if they don’t pass it, they’re stuck with the Affordable Care Act.

New this morning from PRWeek
Trek Bicycle has a new AOR. The company hired M Booth after an agency search involving 12 firms. Taco Bell introduced fans to a new menu item with a speakeasy. Campaign: How one digital agency is recruiting summer interns with a chatbot.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.